SAFETY AND EFFICACY OF LAQUINIMOD FOR MODERATE TO SEVERE CROHN’S DISEASE: A PHASE IIA DOUBLE-BLIND PLACEBO CONTROLLED DOSE FINDING STUDY

(1) University of Amsterdam

(2) Centre Hospitalier Universitaire (CHU)

(3) University of Califonia

(4) Catholic University of Leuven

(5) University of Western Ontario



This item was part of the Novel therapies in IBD session at 20th United European Gastroenterology Week

This item can be cited as: Gut 2012; 61 (Suppl 3) A66